1. Home
  2. KRON

KRON

Kronos Bio Inc.

Logo Kronos Bio Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-23-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.

Founded: 2017 Country:
N/A
Employees: N/A City: SAN MATEO
Market Cap: 61.9M IPO Year: 2020
Target Price: $4.25 AVG Volume (30 days): 281.8K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.95 EPS Growth: N/A
52 Week Low/High: $0.73 - $2.29 Next Earning Date: 01-01-0001
Revenue: $6,288,000 Revenue Growth: N/A
Revenue Growth (this year): -3.21% Revenue Growth (next year): -45.19%

Share on Social Networks: